Cargando…
Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective
Acid sphingomyelinase deficiency (ASMD), historically known as Niemann–Pick disease (NPD) types A, A/B, and B, is a rare, progressive, potentially fatal lysosomal storage disease with a spectrum of phenotypes. Little is known about how ASMD symptoms affect the lives of patients and their caregivers....
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546120/ https://www.ncbi.nlm.nih.gov/pubmed/34697402 http://dx.doi.org/10.1038/s41598-021-99921-6 |
_version_ | 1784590124206522368 |
---|---|
author | Pokrzywinski, Robin Hareendran, Asha Nalysnyk, Luba Cowie, Sandy Crowe, Joslyn Hopkin, Justin Joshi, Dhaivat Pulikottil-Jacob, Ruth |
author_facet | Pokrzywinski, Robin Hareendran, Asha Nalysnyk, Luba Cowie, Sandy Crowe, Joslyn Hopkin, Justin Joshi, Dhaivat Pulikottil-Jacob, Ruth |
author_sort | Pokrzywinski, Robin |
collection | PubMed |
description | Acid sphingomyelinase deficiency (ASMD), historically known as Niemann–Pick disease (NPD) types A, A/B, and B, is a rare, progressive, potentially fatal lysosomal storage disease with a spectrum of phenotypes. Little is known about how ASMD symptoms affect the lives of patients and their caregivers. In a cross-sectional qualitative study conducted in the US and UK, and in collaboration with the National Niemann–Pick Disease Foundation (US) and Niemann–Pick UK, we investigated the symptom experience of patients with ASMD types B and A/B and explored how the disease impacts their and their caregivers’ lives. The study included 17 adult patients (mean age 38.7 years, 12 female), three caregivers of adults with ASMD, 12 pediatric/adolescent patients with ASMD (mean age 10.5 years, six female), and 12 caregivers of pediatric/adolescent patients with ASMD. The most commonly reported disease manifestations were respiratory (n = 26, 89.7%), abdominal (n = 25, 86.2%), and musculoskeletal symptoms (n = 23, 79.3%); excessive bleeding or bruising (n = 20, 69%); fatigue (n = 20, 69%); gastrointestinal symptoms (n = 18, 62.1%); and headache (n = 15, 51.7%). ASMD was reported to negatively impact patients’ physical function (n = 23, 79.3%), self-esteem (n = 18, 62.1%), emotions (n = 16, 55.2%), social function and relationships (n = 16, 55.2%), and personal care (n = 9, 31%). Providing care for individuals with ASMD negatively affected caregivers’ emotional well-being (n = 12, 80%), social function (n = 4, 26.7%), relationships (n = 6, 40%), and financial security (n = 7, 46.7%). The physical toll of providing care, the need for lifestyle changes, and the responsibility for making medical decisions added to the burden for caregivers. Alternatively, some caregivers noted that caring for a loved one enhanced their spirituality, providing them with a different outlook on life and a deeper personal resolve. This study showed that ASMD is a substantial burden for patients and caregivers, with long-term physical, emotional, social, and financial impacts. The study confirmed commonly known manifestations of ASMD, especially respiratory problems, but also identified less recognized ones, such as dermatological complications. The data collected and insight gained from this study should enhance clinical care, help evaluate new treatments, and inform health care decision making for patients with ASMD. |
format | Online Article Text |
id | pubmed-8546120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-85461202021-10-27 Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective Pokrzywinski, Robin Hareendran, Asha Nalysnyk, Luba Cowie, Sandy Crowe, Joslyn Hopkin, Justin Joshi, Dhaivat Pulikottil-Jacob, Ruth Sci Rep Article Acid sphingomyelinase deficiency (ASMD), historically known as Niemann–Pick disease (NPD) types A, A/B, and B, is a rare, progressive, potentially fatal lysosomal storage disease with a spectrum of phenotypes. Little is known about how ASMD symptoms affect the lives of patients and their caregivers. In a cross-sectional qualitative study conducted in the US and UK, and in collaboration with the National Niemann–Pick Disease Foundation (US) and Niemann–Pick UK, we investigated the symptom experience of patients with ASMD types B and A/B and explored how the disease impacts their and their caregivers’ lives. The study included 17 adult patients (mean age 38.7 years, 12 female), three caregivers of adults with ASMD, 12 pediatric/adolescent patients with ASMD (mean age 10.5 years, six female), and 12 caregivers of pediatric/adolescent patients with ASMD. The most commonly reported disease manifestations were respiratory (n = 26, 89.7%), abdominal (n = 25, 86.2%), and musculoskeletal symptoms (n = 23, 79.3%); excessive bleeding or bruising (n = 20, 69%); fatigue (n = 20, 69%); gastrointestinal symptoms (n = 18, 62.1%); and headache (n = 15, 51.7%). ASMD was reported to negatively impact patients’ physical function (n = 23, 79.3%), self-esteem (n = 18, 62.1%), emotions (n = 16, 55.2%), social function and relationships (n = 16, 55.2%), and personal care (n = 9, 31%). Providing care for individuals with ASMD negatively affected caregivers’ emotional well-being (n = 12, 80%), social function (n = 4, 26.7%), relationships (n = 6, 40%), and financial security (n = 7, 46.7%). The physical toll of providing care, the need for lifestyle changes, and the responsibility for making medical decisions added to the burden for caregivers. Alternatively, some caregivers noted that caring for a loved one enhanced their spirituality, providing them with a different outlook on life and a deeper personal resolve. This study showed that ASMD is a substantial burden for patients and caregivers, with long-term physical, emotional, social, and financial impacts. The study confirmed commonly known manifestations of ASMD, especially respiratory problems, but also identified less recognized ones, such as dermatological complications. The data collected and insight gained from this study should enhance clinical care, help evaluate new treatments, and inform health care decision making for patients with ASMD. Nature Publishing Group UK 2021-10-25 /pmc/articles/PMC8546120/ /pubmed/34697402 http://dx.doi.org/10.1038/s41598-021-99921-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Pokrzywinski, Robin Hareendran, Asha Nalysnyk, Luba Cowie, Sandy Crowe, Joslyn Hopkin, Justin Joshi, Dhaivat Pulikottil-Jacob, Ruth Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective |
title | Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective |
title_full | Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective |
title_fullStr | Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective |
title_full_unstemmed | Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective |
title_short | Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective |
title_sort | impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546120/ https://www.ncbi.nlm.nih.gov/pubmed/34697402 http://dx.doi.org/10.1038/s41598-021-99921-6 |
work_keys_str_mv | AT pokrzywinskirobin impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective AT hareendranasha impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective AT nalysnykluba impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective AT cowiesandy impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective AT crowejoslyn impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective AT hopkinjustin impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective AT joshidhaivat impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective AT pulikottiljacobruth impactandburdenofacidsphingomyelinasedeficiencyfromapatientandcaregiverperspective |